Application for Continuing Education Credit

Name

NHIA Member

Non-Member

License Number License State: Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Company:

Address:
City State: Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Zip:
Phone:
Fax:
Email:
Date Quiz Taken:

Continuing Education Assessment Questions

1. Early symptoms of Guillain-Barré Syndrome (GBS) include which of the following:
a. Paralysis of the legs
b. Loss of bladder control
c. Weakness or tingling in the legs
d. Severe pain the feet and lower legs

2. The peak incidence at which GBS occurs is which age group?
a. 10-20 years of age
b. 30-40 years of age
c. 50-60 years of age
d. 70-80 years of age

3. Symptoms of GBS occur in most patients as a result of the immune system mediated destruction of the myelin sheath that surrounds the axons of many peripheral nerves.
a. True
b. False

4. A positive diagnosis of GBS must include which of the following:
a. Progressive muscle weakness with areflexia (an absence of reflex)
b. Asymmetrical weakness affecting only one side of the body
c. Progression from muscle weakness to paralysis in 24 to 48 hours
d. Fever lasting from five to seven days

5. Chronic idiopathic demyelinating polyneuropathy (CIDP)...
a. Is one of several neuropathies caused by peripheral nerve inflammation
b. May also be referred to as Chronic Relapsing Polyneuropathy
c. Is a syndrome that develops over a progressive course lasting months to years
d. All of the above

6. Early and aggressive treatment of CIDP is important to prevent the loss of nerve axons.
True
False

7. If left untreated, what percentage of CIDP patients will completely recover on their own?
a. 10-20%
b. < 5%
c. 50-60%
d. > 90%

8. GBS and CIDP can be cured if aggressive treatment is initiated in the earliest stage of the disorder.
True
False

9. First-line therapies for GBS, as recommended by the American Academy of Neurology (AAN) include which of the following:
a. Intravenous Immune Globulin (IVIG)
b. Plasma Exchange (PE)
c. Transcutaneous Electrical Nerve Stimulation (TENS)
d. All of the above
e. A and B only

10. Treatment for CIDP can include which of the following:
a. Corticosteroids, plasma exchange and IVIG
b. Physiotherapy with TENS application
c. Chemotherapy, including Cisplatin
d. No treatment is recommended, the syndrome should be allowed to run its course

11. Is this program used to meet your mandatory C.E. requirements?
a. Yes
b. No

12. Job description
a. Owner
b. Manager
c. Employee

13. Age Group
a. 21-30
b. 31-40
c. 41-50
d. 51-60
e. Over 60

14. How long have you been practicing as a home infusion pharmacist?
a. 2 years or less
b. 5 years or less
c. 10 years or less
d. More than 10 years

15. Did this module achieve its stated objectives?
a. Yes
b. No

16. How much of this program can you apply in practice?
a. All
b. Some
c. Very little
d. None

17. How long did it take you to complete both the reading and the quiz?
minutes

By checking this box, I am providing my electronic signature confirming the information entered on this certificate is true.